| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 2 | |
| #2 | Colombia | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Israel | 2 | |
| #5 | Republic of Korea | 2 | |
| #6 | Singapore | 2 | |
| #7 | Brazil | 1 | |
| #8 | Canada | 1 | |
| #9 | Chile | 1 | |
| #10 | Costa Rica | 1 | |
| #11 | Ecuador | 1 | |
| #12 | United States | 1 | |
| #13 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Analysing materials | |
| #5 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bridgeman John Stephen | 16 |
| #2 | Price Nicola Kaye | 14 |
| #3 | John Stephen Bridgeman | 3 |
| #4 | Nicola Kaye Price | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021014174A1 | Tumour infiltrating lymphocyte therapy and uses thereof | |
| AU2019289202A1 | Chimeric growth factor receptors | |
| AU2019213201A1 | Biomarker predictive of tumour infiltrating lymphocyte therapy and uses thereof |